Department of Specialized Surgery, Tokyo Medical and Dental University, Tokyo, Japan.
Ann Thorac Cardiovasc Surg. 2020 Dec 20;26(6):352-358. doi: 10.5761/atcs.oa.19-00300. Epub 2020 Apr 22.
We evaluated the clinical outcomes of aortofemoral bypass (AoFB) and axillofemoral bypass (AxFB) surgeries for complex aortoiliac occlusive disease (AIOD) and compared them from the perspectives of safety and efficacy.
We retrospectively reviewed 21 patients with AoFB grafting and 9 patients with AxFB grafting. The demographic information of the patients was examined, and the intra-, peri-, and postoperative results as well as long-term outcomes were evaluated.
In the AoFB, 2 of 21 (9.5%) cases had intra- and perioperative complications, and 4 of 21 (19.0%) cases had postoperative complications; however, there were no postoperative mortalities. In the AxFB, two of nine (22.2%) cases had postoperative graft thrombosis; however, again there were no postoperative mortalities. According to Kaplan-Meier analysis, the primary patency rates in the AoFB and AxFB groups at 5 years were 94.8% and 53.6%, respectively (P = 0.001), while the limb salvage rates at 5 years were 96.4% and 92.9%, respectively (P = 0.320).
Even though the patency rates with AxFB grafting were inferior to those with AoFB grafting, AxFB was able to achieve equivalent limb salvage rates and should thus be considered as an alternative treatment method, especially when limb salvage is a goal.
我们评估了主动脉-股动脉旁路(AoFB)和腋-股动脉旁路(AFB)手术治疗复杂主髂动脉闭塞性疾病(AIOD)的临床效果,并从安全性和有效性的角度对其进行了比较。
我们回顾性分析了 21 例行 AoFB 移植术和 9 例行 AFB 移植术的患者。检查了患者的人口统计学信息,并评估了术中、围术期和术后结果以及长期结果。
在 AoFB 中,21 例中有 2 例(9.5%)发生术中及围术期并发症,4 例(19.0%)发生术后并发症;但无术后死亡病例。在 AFB 中,9 例中有 2 例(22.2%)发生术后移植物血栓形成;但也无术后死亡病例。根据 Kaplan-Meier 分析,AoFB 和 AFB 组的 5 年原发通畅率分别为 94.8%和 53.6%(P=0.001),5 年肢体存活率分别为 96.4%和 92.9%(P=0.320)。
尽管 AFB 移植术的通畅率低于 AoFB 移植术,但 AFB 能够达到等效的肢体存活率,因此应被视为一种替代治疗方法,尤其是在保肢是目标的情况下。